Business NewsPR NewsWire • Medivir AB - Interim Report January - June 2019

Medivir AB - Interim Report January - June 2019

Medivir AB - Interim Report January - June 2019

STOCKHOLM, Aug. 28, 2019 /PRNewswire/ -- April – June Significant events during the quarter Selective effect signal on liver cancer tissue in phase Ia study with MIV-818. The analysis shows an early indication that MIV-818 works as expected, i.e. the substance has the intended...

View More : https://www.prnewswire.com:443/news-releases/medivir-ab--interim-report-january--june-2019-300908276.html
Releted News by prnewswire
Dr. Jon Connelly Opens a New Office in Boca Raton to Help Trauma Victims in Florida Relieve Their Suffering
Umbilical Cord Blood Banking Market to Expand at a Strong 11.4% CAGR, Vast Applications in Cell-based Therapies to Boost Rapid Expansion - TMR
Weltwasserwoche beginnt mit Aufrufen zu Maßnahmen für Gleichstellung beim Thema Wasser
Medivir AB - Interim Report January - June 2019
Australierin Macinley Butson mit Stockholm Junior Water Prize 2019 ausgezeichnet
Oncopeptides AB: Interim Report Q2 2019